I will be presenting the YELLOW III as a late-breaking clinical trial at ACC in New Orleans on Saturday. This is the latest in our series of YELLOW trials on lipid reduction. Join me at 12:45pm, room 257! #acc2023 #yellowIII #cardiotwitter #cardiology #interventionalcardiology

Nope. Not happening until I find out what this gets me , ABIM Foundation. ⁩ What are we paying for? I’m certified…I took my boards and passed them.

📑#SCAI2024 #TAVR Featured Abstract: "A Meta-Analysis Comparision of Post TAVR Antithrombotic Regimens" Ankur Sethi Emily Hiltner Marc Sandhaus Mark Russo ➡️bit.ly/3whq0A4 SCAI Mtg Abstract Issue #JSCAI💡

The waiting game: Delaying #TAVR increases healthcare costs by $10K per year #cardiology #cardiotwitter Cardiovascular Research Foundation Ankur Sethi Robert Wood Johnson University Hospital Rutgers RWJMS Cardiology Fellowship @rwjmsmedicine ow.ly/sLTY50SmlmM

On Sunday, January 28, Luis Padron's day began like any other, but a sudden cardiac arrest changed everything. Thanks to his wife's quick actions and the exceptional care team at Robert Wood Johnson University Hospital, Luis made a miraculous recovery. rwjbh.org/patient-storie…

Latest paper from our team ⁦Mark Russo⁩ #valvecenter ⁦Robert Wood Johnson University Hospital⁩ ⁦Robert Wood Johnson University Hospital⁩ ⁦NJ Chapter of ACC⁩ ⁦SCAI⁩ ⁦American College of Cardiology⁩ ⁦Rutgers RWJMedSchool⁩ ⁦Abbott Cardiovascular⁩ ⁦Edwards Lifesciences⁩ ⁦Medtronic Structural Heart⁩ ⁦⁦ jtcvsstructural.org/article/S2950-…

February 22 is #ValveDiseaseDay! Help spread awareness by educating your patients on the symptoms and prevention of #ValveDisease. Early detection saves lives! #ListenToYourHeart🫀💪 Learn more➡️ Valvediseaseday.org ValveDiseaseDay

🚨#TAVR & #Antithrombotic Therapy: What’s the Evidence? 📌 Key takeaway: After TAVR for #AS, #NOACs may increase mortality in pts w/o a clear need for #anticoagulation. Read more💡 ➡️doi.org/10.1016/j.jsca… Ankur Sethi Marc Sandhaus Emily Hiltner